Charles Sang - Net Worth and Insider Trading
Charles Sang Net Worth
The estimated net worth of Charles Sang is at least $0 dollars as of 2024-11-13. Charles Sang is the SVP, External Affairs of Adaptive Biotechnologies Corp and owns about 0 shares of Adaptive Biotechnologies Corp (ADPT) stock worth over $0. Details can be seen in Charles Sang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Sang has not made any transactions after 2020-12-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles Sang
Charles Sang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Sang owns 1 companies in total, including Adaptive Biotechnologies Corp (ADPT) .
Click here to see the complete history of Charles Sang’s form 4 insider trades.
Insider Ownership Summary of Charles Sang
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2020-12-11 | SVP & Clinical Diagnostics |
Charles Sang Latest Holdings Summary
Charles Sang currently owns a total of 1 stock. Charles Sang owns 0 shares of Adaptive Biotechnologies Corp (ADPT) as of December 11, 2020, with a value of $0.
Latest Holdings of Charles Sang
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | 2020-12-11 | 0 | 5.94 | 0 |
Holding Weightings of Charles Sang
Charles Sang Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Sang has made a total of 3 transactions in Adaptive Biotechnologies Corp (ADPT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Adaptive Biotechnologies Corp is the sale of 50,000 shares on December 11, 2020, which brought Charles Sang around $3 Million.
Insider Trading History of Charles Sang
- 1
Charles Sang Trading Performance
Charles Sang Ownership Network
Ownership Network List of Charles Sang
Ownership Network Relation of Charles Sang
Charles Sang Owned Company Details
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Charles Sang is the SVP & Clinical Diagnostics of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include SVP and General Counsel Stacy L Taylor , Chief Commercial Ofc Imm Med Sharon Benzeno , and Chief Financial Officer Tycho Peterson .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Charles Sang made no insider transaction in Adaptive Biotechnologies Corp (ADPT). Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 258,417 shares made by Tycho Peterson , a net sale of 40,303 shares made by Stacy L Taylor , and a net sale of 7,986 shares made by Kyle Piskel .
In summary, during the past 3 months, insiders sold 26,922 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 26,922 shares. During the past 18 months, 467,732 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 467,732 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
Charles Sang Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Sang. You might contact Charles Sang via mailing address: C/o Adaptive Biotechnologies Corporation, 1551 Eastlake Ave E Ste 200, Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
